Related references
Note: Only part of the references are listed.GATM-Mediated Creatine Biosynthesis Enables Maintenance of FLT3-ITD-Mutant Acute Myeloid Leukemia
Yuan Zhang et al.
MOLECULAR CANCER RESEARCH (2022)
Potential targeting of FLT3 acute myeloid leukemia
Alexander J. Ambinder et al.
HAEMATOLOGICA (2021)
Serine Biosynthesis Is a Metabolic Vulnerability in FLT3-ITD-Driven Acute Myeloid Leukemia
Stefan Bjelosevic et al.
CANCER DISCOVERY (2021)
FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD+ acute myeloid leukemia
Jun Long et al.
BLOOD (2020)
FLT3 Inhibitors Induce Instability of p53 By Mir-181 Mediated Downregulation of Deubiquitinase YOD1 in Acute Myeloid Leukemia
Han Zhong Pei et al.
BLOOD (2020)
Combined inhibition of Notch and FLT3 produces synergistic cytotoxic effects in FLT3/ITD+ acute myeloid leukemia
Dan Li et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF
Aram Ko et al.
CELL DEATH AND DIFFERENTIATION (2018)
MDM2-and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
Katja Seipel et al.
HAEMATOLOGICA (2018)
Pharmacologic inhibition of STAT5 in acute myeloid leukemia
Bettina Wingelhofer et al.
LEUKEMIA (2018)
MDM2-and FLT3-inhibitors in the treatment of FLT3-ITD acute myeloid leukemia, specificity and efficacy of NVP-HDM201 and midostaurin
Katja Seipel et al.
HAEMATOLOGICA (2018)
Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy
Kaiwei Liang et al.
CELL (2018)
Functional genomic landscape of acute myeloid leukaemia
Jeffrey W. Tyner et al.
NATURE (2018)
p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status
A. Quintas-Cardama et al.
LEUKEMIA (2017)
FLT3 inhibition in acute myeloid leukaemia
Naval Daver et al.
LANCET ONCOLOGY (2017)
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling et al.
NATURE REVIEWS CANCER (2017)
Synthetic Lethality of Combined Bcl-2 Inhibition and p53 Activation in AML: Mechanisms and Superior Antileukemic Efficacy
Rongqing Pan et al.
CANCER CELL (2017)
p53 stability is regulated by diverse deubiquitinating enzymes
Seul-Ki Kwon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Dysfunctional diversity of p53 proteins in adult acute myeloid leukemia: projections on diagnostic workup and therapy
Miron Prokocimer et al.
BLOOD (2017)
Results of the Phase I Trial of RG7112, a Small-Molecule MDM2 Antagonist in Leukemia
Michael Andreeff et al.
CLINICAL CANCER RESEARCH (2016)
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
J. S. Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genomic Classification and Prognosis in Acute Myeloid Leukemia
Elli Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
David P. Steensma et al.
BLOOD (2015)
Acute Myeloid Leukemia
Hartmut Doehner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia
Terrence N. Wong et al.
NATURE (2015)
Genomic and Epigenomic Landscapes of Adult De Novo Acute Myeloid Leukemia
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Activation of Ras/PI3K/ERK Pathway Induces c-Myc Stabilization to Upregulate Argininosuccinate Synthetase, Leading to Arginine Deiminase Resistance in Melanoma Cells
Wen-Bin Tsai et al.
CANCER RESEARCH (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
Beclin1 Controls the Levels of p53 by Regulating the Deubiquitination Activity of USP10 and USP13
Junli Liu et al.
CELL (2011)
Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation
Hongkai Ji et al.
PLOS ONE (2011)
USP10 Regulates p53 Localization and Stability by Deubiquitinating p53
Jian Yuan et al.
CELL (2010)
Acetylation is indispensable for p53 activation
Yi Tang et al.
CELL (2008)
Constitutive Fms-like tyrosine kinase 3 activation results in specific changes in gene expression in myeloid leukaemic cells
Kyu-Tae Kim et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Ras inhibition leads to transcriptional activation of p53 and down-regulation of Mdm2: two mechanisms that cooperatively increase p53 function in colon cancer cells
J Halaschek-Wiener et al.
CELLULAR SIGNALLING (2004)
The role of FLT3 in haematopoietic malignancies
DL Stirewalt et al.
NATURE REVIEWS CANCER (2003)
Akt enhances Mdm2-mediated ubiquitination and degradation of p53
Y Ogawara et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
